SecBot SecBot
8-K ·Filed Oct 26, 2026

CTXR

Citius Pharmaceuticals, Inc.
NEUTRAL
Impact 4/10
Processed8h 24m ago SEC0001213900-26-112478
8-K Item 2.02: Earnings release

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-112478
Document: ea030934501ex99-1.htm0001213900-26-112478
Document: 0001213900-26-112478-index-headers.html0001213900-26-112478
Document: 0001213900-26-112478-index.html0001213900-26-112478
Document: 0001213900-26-112478.txt0001213900-26-112478
8-K Data (Synthetic)0001213900-26-112478
8 reports for CTXR
Performance horizon
60% Hit rate @ T+60 3 of 5 directional calls Went positive at some point 4 of 6 best @ T+60▲ +29.16%Apr 24, 2026
Filters
Rows
Reports for CTXR — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
NEUTRAL ★ 4/10
$0.4582awaiting T+60—$0.4490 (−2.01%)
Aug 5, 2026
11w ago
8-K
BULLISH ★ 5/10
$0.7809awaiting T+60—$0.4490 (−42.50%)
Jun 3, 2026
20w ago
EFFECT
BEARISH ★ 6/10
$0.5800 $0.6290▼ −8.45%▼ −5.95%$0.4490 (+22.59%)
Jun 1, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$0.6030 $0.5771▼ −4.30%▼ −5.41%$0.4490 (−25.54%)
May 22, 2026
22w ago
S-3
BEARISH ★ 6/10
$0.6970 $0.6375▲ +8.54%▲ +11.26%$0.4490 (+35.58%)
May 15, 2026
23w ago
8-K
BEARISH ★ 6/10
$0.5270 $0.7650▼ −45.16%▼ −40.31%$0.4490 (+14.80%)
Apr 24, 2026
26w ago
8-K
BEARISH ★ 6/10
$0.6910 $0.5623▲ +18.63%▲ +23.40%$0.4490 (+35.02%)
Apr 24, 2026
26w ago
424B5
BEARISH ★ 6/10
$0.7700 $0.5455▲ +29.16%▲ +34.24%$0.4490 (+41.69%)
Showing 8 of 8

US Market Status

Market Closed — Opens in 8h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh CTXR Intelligence

Analysis is for subscribers only.

Subscribe for Full Access